ELV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ELV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Elevance Health's net income from continuing operations for the three months ended in Mar. 2024 was $2,249 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was $6,236 Mil.
The historical data trend for Elevance Health's Net Income From Continuing Operations can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Net Income From Continuing Operations | Get a 7-Day Free Trial | 4,807.00 | 4,572.00 | 6,149.00 | 5,888.00 | 5,991.00 |
Elevance Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Net Income From Continuing Operations | Get a 7-Day Free Trial | 2,004.00 | 1,856.00 | 1,300.00 | 831.00 | 2,249.00 |
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.
Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,236 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blair Williams Todt | officer: EVP and Chief Legal Officer | 8735 HENDERSON ROAD, TAMPA FL 33625 |
Ronald W Penczek | officer: SVP, Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Mark Kaye | officer: EVP & CFO Designate | 7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007 |
Dixon Robert L Jr | director | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Gloria M Mccarthy | officer: EVP, Office of the CEO | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Kendrick Charles Morgan Jr | officer: EVP & President, Commercial | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Deanna D Strable-soethout | director | C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392 |
Ramiro G Peru | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260 |
Peter D Haytaian | officer: EVP & Pres., Govt. Bus. Div. | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Susan D. Devore | director | C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Ryan M. Schneider | director | 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102 |
John E Gallina | officer: SVP & Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Julie A Hill | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Thomas C Zielinski | officer: EVP & General Counsel | |
Jeffrey D. Alter | officer: EVP, IngenioRx & Anthem Health | 4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122 |
From GuruFocus
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.